Atrial natriuretic peptide (ANP) as an additive to peritoneal dialysis solutions
US5965533A · kind A · utility
5Cited by
4References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 23, 1997 |
| Grant date | Oct 12, 1999 |
| Priority date | — |
| Expiry date | May 23, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P7/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a peritoneal dialysis solution that contains atrial natriuretic peptide (ANP), a derivative of ANP, an analogue of ANP, a substance that binds ANP to clearance receptors or a substance that promotes ANP synthesis, which results in an increased net ultrafiltration and increased sodium clearance experienced in peritoneal dialysis patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.